Skip to Content
MilliporeSigma

Key Documents

View All Documentation

Skip To

D133

6,7-Dichloroquinoxaline-2,3-dione

Synonym(s):

6,7-Dichloro-2,3-quinoxalinedione, DCQX

Sign In to View Organizational & Contract Pricing.

About This Item

Empirical Formula (Hill Notation):
C8H4Cl2N2O2
CAS Number:
25983-13-5
Molecular Weight:
231.04
UNSPSC Code:
12352200
PubChem Substance ID:
24277975
MDL number:
MFCD00078575

SMILES string

Clc1cc2NC(=O)C(=O)Nc2cc1Cl

InChI

1S/C8H4Cl2N2O2/c9-3-1-5-6(2-4(3)10)12-8(14)7(13)11-5/h1-2H,(H,11,13)(H,12,14)

InChI key

AVBSIKMUAFYZAV-UHFFFAOYSA-N

Gene Information

human ... ACHE(43), BCHE(590), CES1(1066), GRIN1(2902)
rat ... Gria1(50592), Grik1(29559), Grin2a(24409)

Biochem/physiol Actions

Antagonist at the NMDA glutamate receptor glycine site.

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

K Ogita et al.
Journal of neurochemistry, 54(2), 699-702 (1990-02-01)
Multiple binding sites on the N-methyl-D-aspartate (NMDA) receptor complex were examined using rat brain synaptic membranes treated with Triton X-100. Binding of [3H](+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imi ne ([3H]MK-801), a noncompetitive NMDA antagonist, in the presence of 10 microM L-glutamate not only was inhibited
R R Matsumoto et al.
European journal of pharmacology, 338(3), 233-242 (1998-01-10)
N-Methyl-D-aspartate (NMDA)/glycine site antagonists were tested for their ability to prevent cocaine-induced convulsions and lethality in Swiss Webster mice. Pre-treatment of mice with the novel NMDA/glycine site antagonists ACEA-1021 (5-nitro-6,7-dichloro-1,4-dihydro-2,3-quinoxalinedione) or ACEA-1328 (5-nitro-6,7-dimethyl-1,4-dihydro-2,3-quinoxalinedione) attenuated cocaine-induced convulsions; these effects were pharmacologically